Clinical Trial Update: Evaluation of the Duration of Oral Combination Therapy in Type 2 Diabetes, Prior to the Initiation of Insulin in the UK

View source ↗

Summary

This completed GlaxoSmithKline-sponsored trial evaluated the duration of oral combination therapy before initiating insulin therapy in adults with Type 2 diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED